Nosox Classic (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑1 adrenergic agonist. When applied to the nasal mucosa it triggers vasoconstriction of the small blood vessels, which reduces swelling and edema, thereby opening the airway and easing breathing.

The exact dose is determined by the prescribing healthcare professional or the product label. For most OTC nasal sprays, the typical recommendation is one or two sprays per nostril, not exceeding two applications within a 24‑hour period, but users should follow the specific guidance provided with the product.

The pregnancy safety category for oxymetazoline is not definitively established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks with their physician before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Oxymetazoline generally provides faster and longer‑lasting relief than phenylephrine, another common OTC nasal decongestant. Both act as sympathomimetics, but oxymetazoline has a higher affinity for alpha‑1 receptors, which often translates into more pronounced vasoconstriction and a lower incidence of rebound congestion when used as directed.

Store the nasal spray at room temperature, away from excessive heat or moisture. Keep the container tightly closed when not in use, protect it from direct sunlight, and store it out of reach of children.

Nosox Classic is applied intranasally. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the recommended number of sprays. The same procedure is repeated for the other nostril if required.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant increases in blood pressure, tachycardia, and rare allergic reactions such as angioedema or anaphylaxis. Users should discontinue the product and seek medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to oxymetazoline or any component of the formulation should avoid the product. It is also contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and in children younger than six years unless directed by a healthcare professional.